Transplantation News

Disparities in receipt of liver transplantation and mortality persisted over time among hospitalized Black and Hispanic patients with decompensated cirrhosis compared with their white counterparts, according to data in JAMA Network Open.

EASL Congress 2023 has ended but, as the society’s official media partner, Healio was at the forefront covering the latest in liver disease. Wondering what you may have missed? Healio recaps the biggest news disrupting the specialty.

Nearly 75% of patients with end-stage liver disease in safety-net hospitals were not referred for liver transplant evaluation, mostly due to active alcohol use or insurance issues, according to data published in JAMA Network Open.

A home-based, prehabilitation program for liver transplant candidates that included financial incentives and text reminders increased walking by one-third over baseline, according to data presented at EASL Congress.

Healio will present its sixth annual Disruptive Innovators Awards for gastroenterology and hepatology this fall.

The Global Liver Institute has marked June 8 as International NASH Day, part of a public education campaign to raise awareness and urgency about fatty liver disease and its advanced form, nonalcoholic steatohepatitis.

Transplant medicine and the field of transplant infectious diseases have faced numerous disruptions and challenges during the COVID-19 pandemic, according to experts.

CHICAGO — In a Healio video exclusive, Sarah Khan, MD, explains that patients with advanced liver disease and concurrent fungal infection had worse acute-on-chronic liver failure and higher mortality than those with bacterial infection.

CHICAGO — Researchers reported a 262% increase in liver transplantation for acute-on-chronic liver failure in older patients from 2005 to 2021, with alcohol-related liver disease becoming the leading cause during the COVID-19 pandemic.

In a Healio video exclusive, Lauren Nephew, MD, MSCE, winner of the 2022 Healio Rising Disruptor Award, discussed her continued work in moving the needle toward health equity in hepatology, specifically for liver transplantation and cancer.